Newport Wealth Strategies’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.01M Buy
4,104
+640
+18% +$164K 0.61% 35
2021
Q2
$856K Sell
3,464
-30
-0.9% -$7.17K 0.49% 40
2021
Q1
$799K Buy
3,494
+244
+8% +$56K 0.5% 41
2020
Q4
$663K Hold
3,250
0.5% 42
2020
Q3
$661K Buy
3,250
+500
+18% +$101K 0.49% 42
2020
Q2
$530K Sell
2,750
-640
-19% -$120K 0.48% 42
2020
Q1
$618K Buy
3,390
+210
+7% +$38.4K 0.58% 38
2019
Q4
$608K Sell
3,180
-200
-6% -$35.9K 0.44% 44
2019
Q3
$567K Sell
3,380
-405
-11% -$69.3K 0.52% 42
2019
Q2
$655K Sell
3,785
-618
-14% -$104K 0.6% 39
2019
Q1
$760K Sell
4,403
-2,760
-39% -$468K 0.77% 33
2018
Q4
$1.17M Buy
7,163
+4,490
+168% +$761K 1.6% 22
2018
Q3
$445K Buy
+2,673
New +$460K 0.57% 44

Other funds holding VHT

Newport Wealth Strategies's VHT Position: Q3 2021 in Review

Newport Wealth Strategies increased its Vanguard Health Care ETF (VHT) stake by 18% in Q3 2021, buying an estimated $164K and bringing the position to 4,104 shares worth $1.01M. The position accounts for 0.61% of the portfolio, ranked #35.

Newport Wealth Strategies first reported a position in VHT in Q3 2018 and has held it in 13 quarters since. The position peaked at $1.17M in Q4 2018. 773 funds tracked by Wall St. Rank hold VHT as of Q3 2021.

  • Newport Wealth Strategies held 4,104 shares of Vanguard Health Care ETF worth $1.01M as of Q3 2021.
  • Newport Wealth Strategies bought 640 Vanguard Health Care ETF shares in Q3 2021, an estimated $164K.
  • Vanguard Health Care ETF made up 0.61% of Newport Wealth Strategies's portfolio in Q3 2021, its #35 holding.
  • Newport Wealth Strategies first reported a position in Vanguard Health Care ETF in Q3 2018 and has held it in 13 quarters since.
  • Newport Wealth Strategies's Vanguard Health Care ETF position peaked at $1.17M in Q4 2018.
  • 773 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2021.

Based on Newport Wealth Strategies's 13F filing for Q3 2021, filed 12 Nov 2021.